March 25, 2020 / 12:29 PM / 7 days ago

BRIEF-Forge Therapeutics Entered Into A Research Collaboration And Option Agreement With Hoffmann-La Roche

March 25 (Reuters) - Roche Holding AG:

* FORGE THERAPEUTICS, INC. - ENTERED INTO A RESEARCH COLLABORATION AND OPTION AGREEMENT WITH HOFFMANN-LA ROCHE LTD.

* FORGE THERAPEUTICS, INC. - ROCHE HAS AN EXCLUSIVE OPTION TO LICENSE FG-LPXC LUNG PROGRAM FROM FORGE

* FORGE THERAPEUTICS, INC. - ELIGIBLE TO RECEIVE UP TO $190.5 MILLION IN TOTAL PAYMENTS Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below